Alan Hoffman, one of the participants in the first GU nilotinib trial for PD, has just added a new post to his blog.
Towards the end of the post (2nd last paragraph) he makes reference to Tasigna (which he is taking).
The Continuing Saga of an Adventurous Life with Parkinson's Disease